1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
136.18 -1.19 (-0.87%)
1.2M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Insider Trade
Gano Kyle, CEO of Neurocrine Biosciences, sells over 36K shares worth $4.8 million See details